[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":360909000.0,"IncomeLossFromContinuingOperationsPerBasicShare_2_Q2_USD":-0.07,"IncomeLossFromContinuingOperationsPerBasicShare_1_Q2_USD":0.09,"DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_0_Q2_USD":0.0,"AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_0_Q2_USD":0.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":14300000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":6600000.0,"AccountsReceivableGrossCurrent_0_Q2_USD":1386562000.0,"RepaymentsOfLinesOfCredit_2_Q2_USD":527500000.0,"ProceedsFromLinesOfCredit_2_Q2_USD":527500000.0,"ProceedsFromIssuanceOfSeniorLongTermDebt_2_Q2_USD":0.0,"PaymentsToAcquireInvestments_2_Q2_USD":32335000.0,"OtherAssetsCurrent_0_Q2_USD":41083000.0,"IncomeLossFromEquityMethodInvestments_2_Q2_USD":1824000.0,"IncomeLossFromEquityMethodInvestments_1_Q2_USD":479000.0,"AvailableForSaleSecurities_0_Q2_USD":90642000.0,"AccruedSalariesCurrent_0_Q2_USD":131739000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":2078000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":509203000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":1071054000.0,"CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_2_Q2_USD":0.0,"CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_2_Q2_USD":15466000.0,"IncomeLossFromDiscontinuedOperationsNetOfTax_2_Q2_USD":-684999000.0,"IncomeLossFromDiscontinuedOperationsNetOfTax_1_Q2_USD":-680036000.0,"IncomeLossFromContinuingOperationsPerDilutedShare_1_Q2_USD":0.09,"DeferredIncomeTaxAssetsNet_0_Q2_USD":61227000.0,"DepreciationDepletionAndAmortization_1_Q2_USD":14393000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":28792000.0,"IncomeTaxesReceivable_0_Q2_USD":64428000.0,"StockRepurchasedDuringPeriodValue_1_Q2_USD":501000.0,"EarningsPerShareDiluted_1_Q2_USD":-8.03,"EarningsPerShareDiluted_2_Q2_USD":-8.32,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":55812000.0,"IncomeLossFromContinuingOperationsPerDilutedShare_2_Q2_USD":-0.07,"OtherLiabilitiesNoncurrent_0_Q2_USD":52980000.0,"PaymentsOfFinancingCosts_2_Q2_USD":510000.0,"MalpracticeLossContingencyAccrualUndiscountedCurrent_0_Q2_USD":57466000.0,"MalpracticeLossContingencyAccrualUndiscountedNoncurrent_0_Q2_USD":260936000.0,"NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_2_Q2_USD":-37125000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":21598000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":56936000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":75817000.0,"LineOfCreditFacilityRemainingBorrowingCapacity_0_Q2_USD":899800000.0,"OtherNoncashIncomeExpense_2_Q2_USD":2092000.0,"PaymentForContingentConsiderationLiabilityOperatingActivities_2_Q2_USD":102000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":75000.0,"PaymentsToAcquireOtherPropertyPlantAndEquipment_2_Q2_USD":23326000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":18135000.0,"ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_2_Q2_USD":476000.0,"RepaymentsOfLongTermCapitalLeaseObligations_2_Q2_USD":186000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_2_Q2_USD":1248000.0,"NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_Q2_USD":19893000.0,"LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_0_Q2_USD":0.0,"InvestmentIncomeNet_2_Q2_USD":3172000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":255000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":7489000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":2785000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":90642000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":24281000.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":1426000.0,"LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_0_Q2_USD":0.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_1_Q2_USD":-8.14,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_1_Q2_USD":-8.12,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_2_Q2_USD":-8.25,"IncreaseDecreaseInAccruedIncomeTaxesPayable_2_Q2_USD":-49757000.0,"IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve_2_Q2_USD":2931000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":-5560000.0,"InvestmentIncomeNet_1_Q2_USD":3851000.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_2_Q2_USD":-8.25,"NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_2_Q2_USD":-611000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1004786000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":46956000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":16281000.0,"Liabilities_0_Q2_USD":2560642000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":3387212000.0,"LiabilitiesCurrent_0_Q2_USD":383933000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-611000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-21659000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-44296000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":46551000.0,"NetIncomeLoss_1_Q2_USD":-672436000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":4376000.0,"ProfitLoss_2_Q2_USD":-691148000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":98469000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-179071000.0,"StockholdersEquity_0_Q2_USD":826570000.0,"NetIncomeLoss_2_Q2_USD":-691148000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"IncomeTaxExpenseBenefit_2_Q2_USD":6109000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-40000.0,"AccountsPayableCurrent_0_Q2_USD":48982000.0,"AccountsReceivableNetCurrent_0_Q2_USD":345682000.0,"AccruedIncomeTaxesCurrent_0_Q2_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":1335000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":1092000.0,"Assets_0_Q2_USD":3387212000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":3373000.0,"AssetsCurrent_0_Q2_USD":688329000.0,"CommonStockSharesIssued_0_Q2_shares":85536000.0,"CommonStockSharesOutstanding_0_Q2_shares":85536000.0,"CommonStockValue_0_Q2_USD":855000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":77674000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":165232000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":10973000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":132151000.0,"RestructuringCharges_1_Q2_USD":11537000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"InterestExpense_2_Q2_USD":55931000.0,"PrepaidExpenseCurrent_0_Q2_USD":14343000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":826570000.0,"EarningsPerShareBasic_1_Q2_USD":-8.05,"EarningsPerShareBasic_2_Q2_USD":-8.32,"Goodwill_0_Q2_USD":2165020000.0,"IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":7600000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":200408000.0,"IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":-6149000.0,"NonoperatingIncomeExpense_2_Q2_USD":-50935000.0,"OtherAssetsNoncurrent_0_Q2_USD":97942000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":2544000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":83490000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":83061000.0,"CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_2_Q2_USD":26658000.0,"NonoperatingIncomeExpense_1_Q2_USD":-23935000.0,"InterestExpense_1_Q2_USD":28265000.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":26888000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":68681000.0,"InterestPayableCurrent_0_Q2_USD":32679000.0,"OperatingExpenses_1_Q2_USD":474295000.0,"OperatingExpenses_2_Q2_USD":1020159000.0,"OperatingIncomeLoss_1_Q2_USD":34908000.0,"OperatingIncomeLoss_2_Q2_USD":50895000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":3043000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-86609000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockValue_0_Q2_USD":0.0,"ShareBasedCompensation_2_Q2_USD":13819000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":83745000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":83061000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":1040880000.0,"PreferredStockSharesAuthorized_0_Q2_shares":1000000.0,"RestructuringCharges_2_Q2_USD":30581000.0,"Ticker":"MD","CIK":"893949","name":"MEDNAX, INC.","OfficialName":"Mednax Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2069794690.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NYSE","SP500":"nan","filed":"20200730"}]